Dan Tudor Eniu
Overview
Explore the profile of Dan Tudor Eniu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
153
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Agiannitopoulos K, Pepe G, Tsaousis G, Potska K, Bouzarelou D, Katseli A, et al.
Cancer Genomics Proteomics
. 2023 Aug;
20(5):448-455.
PMID: 37643779
Background/aim: Germline copy number variation (CNV) is a type of genetic variant that predisposes significantly to inherited cancers. Today, next-generation sequencing (NGS) technologies have contributed to multi gene panel analysis...
2.
Fekete Z, Tertan B, Raduly L, Eniu D, Buiga R, Galatar M, et al.
Infect Agent Cancer
. 2023 Jun;
18(1):39.
PMID: 37340312
Background: Breast cancer, although the most frequently diagnosed malignant tumor in humans, has a less clear etiology compared to other frequent cancer types. Mouse-mammary tumor virus (MMTV) is involved in...
3.
Goidescu I, Nemeti G, Surcel M, Caracostea G, Florian A, Cruciat G, et al.
Cancers (Basel)
. 2023 Mar;
15(6).
PMID: 36980780
(1) Background: Multigene panel testing for Hereditary Breast and Ovarian Cancer (HBOC) using next generation sequencing (NGS) is becoming a standard in medical care. There are insufficient genetic studies reported...
4.
Tsaousis G, Papadopoulou E, Agiannitopoulos K, Pepe G, Tsoulos N, Boukovinas I, et al.
Cancer Genomics Proteomics
. 2021 Dec;
19(1):60-78.
PMID: 34949660
Background/aim: The use of multi-gene panels for germline testing in breast cancer enables the estimation of cancer risk and guides risk-reducing management options. The aim of this study was to...
5.
Nistor-Ciurba C, Lisencu I, Tat T, Andries A, Fetica B, Cainap C, et al.
Rom J Morphol Embryol
. 2021 Oct;
62(1):125-132.
PMID: 34609415
Our article presents some of the challenges of the surgical treatment of T4 (>15 cm) retroperitoneal liposarcomas (up to 65∕56∕30 cm, 25.5 kg) series of cases treated by the Department...
6.
Agiannitopoulos K, Pepe G, Papadopoulou E, Tsaousis G, Kampouri S, Maravelaki S, et al.
Cancer Genomics Proteomics
. 2021 Apr;
18(3):285-294.
PMID: 33893081
Background: Classification of splicing variants (SVs) in genes associated with hereditary cancer is often challenging. The aim of this study was to investigate the occurrence of SVs in hereditary cancer...
7.
Rachieriu C, Eniu D, Mois E, Graur F, Socaciu C, Socaciu M, et al.
Biomolecules
. 2021 Apr;
11(3).
PMID: 33799830
Metabolomics coupled with bioinformatics may identify relevant biomolecules such as putative biomarkers of specific metabolic pathways related to colorectal diagnosis, classification and prognosis. This study performed an integrated metabolomic profiling...
8.
Nistor-Ciurba C, Somcutian O, Lisencu I, Ignat F, Lazar G, Eniu D
Rom J Morphol Embryol
. 2020 Aug;
61(1):129-135.
PMID: 32747903
Phyllodes tumors of the breast are biphasic tumors consisting from an epithelial component and a mesenchymal component. Usually, the mesenchymal component of the tumor is the one who dictates the...
9.
Eniu D, Staicu A, Somcutian O, Buiga R, Albu C, Goidescu I, et al.
Rom J Morphol Embryol
. 2020 Apr;
60(4):1317-1321.
PMID: 32239111
We present the clinical and pathological aspects of a patient diagnosed with a very rare tumor, a blue nevus-like melanoma of the uterine cervix. The patient turned to our Service...
10.
Nistor-Ciurba C, Buiga R, Popita C, Eniu D, Puscas M, Ignat F
Rom J Morphol Embryol
. 2020 Jan;
60(3):979-983.
PMID: 31912112
Phyllodes tumors (PTs) are a group of rarely breast tumors of fibro-epithelial origin, counting for about 1% of the breast malignancies divided, based on histological features, in benign, borderline and...